Misplaced Pages

ZK-283197

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Chemical compound Pharmaceutical compound
ZK-283197
Clinical data
Other namesBAY 86-5310; SH-T04211C; ZK283197
Routes of
administration
By mouth
Drug classEstrogen; Selective ERβ agonist
Legal status
Legal status
  • Investigational
Identifiers
CAS Number
PubChem CID
PubChem SID
UNII
Chemical and physical data
FormulaC20H25FO2
Molar mass316.416 g·mol
3D model (JSmol)
SMILES
  • C12CC3((1C(2F)O)CCC4=C3C=CC(=C4)O)C=C
InChI
  • InChI=1S/C20H25FO2/c1-3-20-9-8-19(2)16(11-17(23)18(19)21)15(20)6-4-12-10-13(22)5-7-14(12)20/h3,5,7,10,15-18,22-23H,1,4,6,8-9,11H2,2H3/t15-,16-,17+,18-,19-,20+/m0/s1
  • Key:LXLNOGZWGYFWQV-CFSBILQPSA-N

ZK-283197 (also known as BAY 86-5310 or SH-T04211C) is a selective and orally active ERβ agonist which was under development by Bayer Healthcare AG for the treatment of vasomotor symptoms. It reached phase II clinical trials prior to the discontinuation of its development. Its development was terminated in 2014.

References

  1. ^ "ZK 283197". AdisInsight. Springer Nature Switzerland AG.
  2. US 332204, Pietras RJ, Jung ME, "Methods of using estrogen receptor-beta ligands as radiation mitigators", published 2015-01-15 
Estrogen receptor modulators
ERTooltip Estrogen receptor
Agonists
Mixed
(SERMsTooltip Selective estrogen receptor modulators)
Antagonists
  • Coregulator-binding modulators: ERX-11
GPERTooltip G protein-coupled estrogen receptor
Agonists
Antagonists
Unknown
See also
Receptor/signaling modulators
Estrogens and antiestrogens
Androgen receptor modulators
Progesterone receptor modulators
List of estrogens


Stub icon

This drug article relating to the genito-urinary system is a stub. You can help Misplaced Pages by expanding it.

Stub icon

This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it.

Categories: